These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36052956)

  • 1. Letter: Predictive Value of Systemic Immune-Inflammatory Index in No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction.
    Liu JH; Zeng M; Zhang Y; Mo DG
    Angiology; 2023 Apr; 74(4):395-396. PubMed ID: 36052956
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of syntax score and syntax score II to predict "no reflow phenomenon" in patients with ST-segment elevation myocardial infarction.
    Yesin M; Çağdaş M; Kalçık M; Uluganyan M; Efe SÇ; Rencüzoğulları İ; Karabağ Y; Gürsoy MO; Karakoyun S
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1883-1889. PubMed ID: 28664479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
    Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to the letter regarding the article "Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention".
    Celik T; Ozturk C; Balta S; Yildirim AO
    Cardiol J; 2016; 23(5):589-590. PubMed ID: 27723055
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.
    Çelik MC; Karayiğit O; Ozkan C; Dolu AK; Kalçık M
    Angiology; 2023 Apr; 74(4):387-394. PubMed ID: 35857618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Zhang Q; Hu M; Sun J; Ma S
    Scand Cardiovasc J; 2020 Dec; 54(6):352-357. PubMed ID: 32597237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction.
    Seçkin Göbüt Ö; Ünlü S
    Angiology; 2024 Aug; 75(7):696-697. PubMed ID: 37768690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: The Importance of Stress Hyperglycemia for Poor Outcomes in ST Elevation Myocardial Infarction Patients.
    Cinar T; Erdem A; Selçuk M; Çiçek V; Asal S; Yavuz S; Hayiroglu MI
    Angiology; 2023 Jul; 74(6):596-597. PubMed ID: 36165396
    [No Abstract]   [Full Text] [Related]  

  • 12. D-Dimer Level Predicts Angiographic No-Reflow Phenomenon After Percutaneous Coronary Intervention Within 2-7 Days of Symptom Onset in Patients with ST-Segment Elevation Myocardial Infarction.
    Gong X; Lei X; Huang Z; Song Y; Wang Q; Qian J; Ge J
    J Cardiovasc Transl Res; 2021 Aug; 14(4):728-734. PubMed ID: 32212039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand?
    Bulluck H; Foin N; Tan JW; Low AF; Sezer M; Hausenloy DJ
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28242607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of endothelial dysfunction and no-reflow during primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Levi Y; Sultan A; Alemayehu M; Wall S; Lavi S
    Cardiovasc Revasc Med; 2016 Dec; 17(8):552-555. PubMed ID: 27638105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.
    Durante A; Laricchia A; Benedetti G; Esposito A; Margonato A; Rimoldi O; De Cobelli F; Colombo A; Camici PG
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):e005841. PubMed ID: 28592591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Yang L; Cong H; Lu Y; Chen X; Liu Y
    Medicine (Baltimore); 2020 Jun; 99(26):e20152. PubMed ID: 32590726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients?
    Toprak K; Kaplangöray M; Memioglu T; İnanir M
    Coron Artery Dis; 2023 Jun; 34(4):281. PubMed ID: 37102231
    [No Abstract]   [Full Text] [Related]  

  • 19. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
    BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention.
    Dogdus M; Yenercag M; Ozyasar M; Yilmaz A; Can LH; Kultursay H
    Angiology; 2021 Mar; 72(3):221-227. PubMed ID: 32996338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.